Copenhagen Biotech Biograil Secures €20 Million Series A to Advance Oral Drug Delivery Platform
Copenhagen‑based biotech startup Biograil raised €20 million in a funding round led by Verve Ventures and backed by several European investors to push its BIONDD oral capsule technology toward Phase 1 clinical trials.